tiprankstipranks
Holding TSE:ARKG?
Track your performance easily

TSE:ARKG Price & Analysis

ARKG ETF Chart & Stats

Day’s Range― - ―
52-Week RangeC$9.94 - C$16.25
Previous CloseC$10.8
VolumeN/A
Average Volume (3M)5.61K
AUM4.42M
NAV10.79
Expense Ratio0.96%
Holdings Count40
Beta1.86
Inception DateNov 14, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares Outstanding400,060
Standard Deviation0.12
10 Day Avg. Volume2,647
30 Day Avg. Volume5,609
Alpha-0.02

BMO ARK Genomic Revolution Fund Trust Units A (ARKG) Fund Flow Chart

BMO ARK Genomic Revolution Fund Trust Units A (ARKG) 1 year Net Flows: C$3M

ARKG ETF FAQ

What was TSE:ARKG’s price range in the past 12 months?
TSE:ARKG lowest ETF price was C$9.94 and its highest was C$16.25 in the past 12 months.
    What is the AUM of TSE:ARKG?
    As of May 08, 2024 The AUM of TSE:ARKG is 4.42M.
      Is TSE:ARKG overvalued?
      According to Wall Street analysts TSE:ARKG’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does TSE:ARKG pay dividends?
        TSE:ARKG does not currently pay dividends.
        How many shares outstanding does TSE:ARKG have?
        TSE:ARKG has 400,060 shares outstanding.
          Which hedge fund is a major shareholder of TSE:ARKG?
          Currently, no hedge funds are holding shares in TSE:ARKG

          ARKG ETF Smart Score

          For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

          Top 10 Holdings

          Name
          Weight %
          Exact Sciences Corp
          9.19%
          Ionis Pharmaceuticals Inc.
          6.00%
          Pacific Biosciences
          5.46%
          Ginkgo Bioworks Holdings, Inc.
          5.24%
          Schrodinger, Inc.
          4.47%
          Teladoc Inc.
          4.15%
          Crispr Therapeutics
          3.88%
          Intellia Therapeutics Inc
          3.62%
          Accolade, Inc.
          3.58%
          Uipath Inc
          3.47%
          Total49.06%

          ETF Description

          BMO ARK Genomic Revolution Fund Trust Units A

          The fund is an actively managed fund that targets companies involved in the genomics industry.
          Sector
          Sector
          Asset Class
          Equity
          Region
          Global
          Issuer
          BMO
          Index Tracked
          No Underlying Index
          Ticker Symbol
          TSE:ARKG
          Popular ETFs
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis